静脉曲张术后静脉血栓栓塞症需重视抗磷脂综合征检测
本文通过一例病例报告阐述静脉曲张术后静脉血栓栓塞症事件的实践评估方法,强调需权衡血栓与出血风险,并根据表现和触发因素严重程度识别可从抗凝治疗获益的患者;TRAPS研究提示应早期识别抗磷脂综合征患者以降低抗凝期间血栓栓塞风险。
要点
- 静脉曲张术后VTE抗凝决策需个体化权衡血栓与出血风险。
- 评估VTE事件需结合临床表现和触发因素严重程度。
- 应早期识别抗磷脂综合征以降低抗凝治疗期间血栓栓塞风险。
核心结论
- 静脉曲张术后发生VTE时需重视抗磷脂综合征检测,早期识别患者以降低抗凝期间血栓栓塞风险。
研究设计与样本
- 本文为病例报告,用以说明静脉曲张术后静脉血栓栓塞症事件实践处理方法的要点。
主要发现
- 抗凝治疗决策需基于VTE事件表现和触发因素严重程度个体化评估。
- TRAPS研究为抗磷脂综合征患者的抗凝管理带来新的考虑。
关键数值与推荐
- 原文未报告具体数值标准。
临床怎么用
- 对静脉曲张术后VTE患者应评估抗磷脂综合征检测必要性,并个体化权衡抗凝获益与出血风险。
局限性
- 原文未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Anticoagulation treatment after a venous thromboembolism event is usually managed on a case-by-case basis. The risk of thrombosis must be weighed against the risk of bleeding. Identifying patients who could benefit from anticoagulation therapy requires the thromboembolism event to be assessed with respect to its presentation and the severity of the triggering factors. A case report is employed to explain the important aspects of practical approaches to venous thromboembolism events after vein surgery. The Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) study has prompted new considerations for anticoagulation management. Patients with antiphospholipid syndrome need to be identified early to lower the risk of thromboembolism also during anticoagulation treatment.
引用
- Wahl U, Hirsch T. The importance of antiphospholipid syndrome testing in venous thromboembolism after varicose vein surgery. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32381473. doi:10.1016/j.jvsv.2020.03.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。